Spotlight on Darbepoetin Alfa in the Treatment of Anemia in Patients with Cancer Receiving Chemotherapy

Author： Siddiqui M. Asif A.   Keating Gillian M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.5, 2006-01, pp. : 321-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

By Schwartzberg L.   Shiffman R.   Tomita D.   Stolshek B.   Rossi G.   Adamson R.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2781-2796

Elsevier

Access to resources Recommend Favorite

Darbepoetin Alfa: Its Use in Anemia Associated with Chronic Kidney Disease

By Robinson Dean M.   Easthope Stephanie E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 327-343

Adis International

Access to resources Recommend Favorite

Spotlight on Pegfilgrastim in Chemotherapy-Induced Neutropenia

By Frampton James E.   Keating Gillian M.  

BioDrugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 405-407

Adis International

Access to resources Recommend Favorite

Spotlight on Trastuzumab as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer†

By Garnock-Jones Karly P.   Keating Gillian M.   Scott Lesley J.  

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 207-209

Adis International

Access to resources Recommend Favorite

Spotlight on Panitumumab in Metastatic Colorectal Cancer†

By Keating Gillian M.  

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 275-278

Adis International

Access to resources Recommend Favorite